Nektar Therapeutics (NKTR) Reports Q3 Loss of 14c/sh

November 7, 2013 4:21 PM

Nektar Therapeutics (NASDAQ: NKTR) reported Q3 EPS of ($0.14), may ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found